Navigation Links
Antibiotic-resistant pathogens persist in antibiotic-free pigs
Date:9/17/2012

Researchers from North Carolina State University have found identical strains of antibiotic-resistant Campylobacter coli (C. coli) in both antibiotic-free (ABF) and conventionally raised pigs. This finding may indicate that these antibiotic-resistant pathogens can persist and thrive in the environment, regardless of antimicrobial usage by pork producers.

Dr. Siddhartha Thakur, assistant professor of population health and pathobiology, had previously found that antibiotic-resistant C. coli, a leading cause of foodborne illness in the U.S., was present in both ABF-certified and conventionally raised pigs. The pathogen was present in both groups in all facilities from breeding to processing. Thakur wanted to determine whether the C. coli that he found in each group was genetically the same, in order to see if the presence or absence of antimicrobial usage had an effect on the pathogen's genetic makeup.

The rise of antibiotic-resistant pathogens like C. coli is a concern for the food animal industry. Some pig farms have switched to raising ABF pigs in an attempt to get away from the conditions that facilitated antibiotic resistance in the first place. The hope is that once the selection pressure in the form of antimicrobial use on C. coli to retain antibiotic resistance decreases, the pathogen will lose its resistance.

Over several years, Thakur and Ph.D. student Macarena Quintana-Hayashi collected thousands of samples from pigs and their surrounding environments, and performed a genetic analysis on 200 representative isolates of C. coli, to see if these strains were similar. They found that the Campylobacter populations in the two swine production systems (conventional and ABF) were in fact the same. Since the different pig populations never came into contact, the researchers concluded that the environment must be playing a large role in the continuing survival of antibiotic-resistant C. coli.

Thakur's findings appear online in PLoS One.

"In the case of ABF pigs, the environment plays an important role in their exposure to these resistant strains," Thakur says. "If the environment itself, and not the pig, is serving as a reservoir for C. coli, then we will most probably continue to find resistant bacterial populations, regardless of a producer's antimicrobial use."


'/>"/>

Contact: Tracey Peake
tracey_peake@ncsu.edu
919-515-6142
North Carolina State University
Source:Eurekalert

Related biology news :

1. Bees self-medicate when infected with some pathogens
2. College students work to sterilize air, kill pathogens on buses
3. Antitoxin strategy may help target other pathogens
4. Differences in the genomes of related plant pathogens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2016)... 2016 --> ... research report "Emotion Detection and Recognition Market by Technology (Bio-Sensors, ... Expression, Voice Recognition and Others), Services, Application Areas, ... 2020", published by MarketsandMarkets, the global Emotion Detection ... 22.65 Billion by 2020, at a CAGR of ...
(Date:1/18/2016)... Calif. , Jan. 18, 2016  Extenua ... software that simplifies the use and access of ... and go-to-market partnership with American Cyber.  ... brings extensive experience leading transformational C4ISR and Cyber ... and integrating the latest proven technology solutions," said ...
(Date:1/11/2016)... Jan. 11, 2016 Synaptics Incorporated (NASDAQ: ... today announced that its ClearPad ® TouchView ™ ... won two separate categories in the 8 th ... Best Technology Breakthrough. The Synaptics ® TDDI solution ... supply chain, thinner devices, brighter displays and borderless designs. ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... , Feb. 10, 2016 NX Prenatal ... its proprietary NeXosome® technology for early warning of ... its most recent study by Dr. Thomas ... the Society for Maternal Fetal Medicine,s (SMFM) annual meeting ... 1-6 th , 2016.  The presentation reported initial ...
(Date:2/10/2016)... New York, and New York, New York (PRWEB) , ... ... ... Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it ... and develop new vaccines and immunotherapies for infectious diseases and cancer. ...
(Date:2/10/2016)... 10, 2016  Allergan plc (NYSE: AGN ) ... Brent Saunders , Allergan,s CEO and President, will be ... session at the RBC Capital Markets Healthcare Conference on ... The New York Palace Hotel in New ... live and can be accessed on Allergan,s Investor Relations ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... three states, announced today the promotion of two long-standing principal investigators (PI) to ... Family Medicine, Clinical Research and Development. , Dr. Laurence Chu, a Benchmark Research ...
Breaking Biology Technology: